ArticleThe oncologist2017

Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results.

Eileen M O'Reilly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.